Biosimilars in the EU
Information guide for healthcare professionals Biosimilars in the EU Prepared jointly by the European Medicines Agency and the European Commission
Download Biosimilars in the EU
Information
Domain:
Source:
Link to this page:
Documents from same domain
Q12 Step 2b Technical and regulatory …
www.ema.europa.euICH guideline Q12 on technical and regulatory considerations for pharmaceutical product lifecycle management EMA/CHMP/ICH/804273/2017 Page 3/36
Guideline on good pharmacovigilance practices …
www.ema.europa.eu9 December 2013 . EMA/816292/2011 Rev 1* Guideline on good pharmacovigilance practices (GVP) Module VII – Periodic safety update report (Rev 1)
Guideline on good pharmacovigilance practices (GVP)
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module IX (Rev 1) EMA/827661/2011 Rev 1 Page 2/25
Guideline on good pharmacovigilance practices …
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module VIII (Rev 3) EMA/813938/2011 Rev 3 Page 2/28
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/70 Document History First Codification History Date New Codification
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/75 10 Document History 11 First Codification History Date New Codification November
Guideline on good pharmacovigilance practices …
www.ema.europa.euharmful physical or psychological effects [DIR 2001/83/EC Art 1(1 6)]. 74 Adverse event (AE); synonym: Adverse experience 75 Any untoward medical occurrence in a patient or clinical- trial subject administered a medicinal product
European Medicines Agency
www.ema.europa.eu© EMEA 2006 2 SPECIFICATIONS: TEST PROCEDURES AND ACCEPTANCE CRITERIA FOR BIOTECHNOLOGICAL/BIOLOGICAL PRODUCTS ICH Harmonised Tripartite Guideline
products1/traditional herbal medicinal products
www.ema.europa.euThere is no expectation that existing herbal medicinal products on the market will be affected by this guideline, with the exception of traditional herbal medicinal products for human use that were already
Q7 Q&A - good manufacturing practice for active ...
www.ema.europa.euICH guideline Q7 on good manufacturing practice for active pharmaceutical ingredients – questions and answers EMA/CHMP/ICH/468930/2015 Page 2/37
Related documents
NAFTA Briefing January 2017 public version-FINAL
cargroup.orgNAFTA Briefing: Trade benefits to the automotive industry and potential consequences of withdrawal from the agreement January 2017
CREATION SELON L’ARBRE DE LA CABALE - …
questions-d-etres.netCREATION SELON L’ARBRE DE LA CABALE L’ARBRE DE VIE forme la base de la Tradition de l’Esotérisme occidental..La Cabale c’est la Sagesse d’Israël , celle des anciens Hébreux .
Microplastics in fisheries and aquaculture
www.fao.org615 Microplastics in fisheries and aquaculture: status of knowledge on their occurrence and implications for aquatic org anisms and food safety
selon la Forme Extraordinaire du Rite Romain - fssp.ch
www.fssp.chCette Messe de funérailles est célébrée dans la Forme Extraordinaire du rite Romain (missel de 1962), suivant les dispositions du Motu Proprio Summorum Pontificum de S.S.
GLOBAL MUSIC REPORT 2017 - IFPI — …
www.ifpi.orgWELCOME Plácido Domingo Chairman, IFPI T he IFPI Global Music Report tells a positive story of music being enjoyed by more people in more ways than ever before. At the heart of this story
Profils de personnalité selon la Process …
www.insight-mediations.com1 D ' a pr è s T a i b i K a h l e r e t P a u l W a r e e t w i k i p e d i a Insight-mediations Profils de personnalité selon la Process Communication Besoins de …